This research aims to evaluate the role of GPX1 as a diagnostic and prognostic biomarker in NK/T cell lymphoma (NKTCL).
Assess clinical associations of GPX1 expression in NKTCL patients
Analyze overall survival (OS) rates related to GPX1 levels
Patients with lower GPX1 expression had significantly lower overall survival rates
GPX1 may serve as a reliable diagnostic and prognostic biomarker for NKTCL
Abstract
PURPOSE: expression with NKTCL. METHODS: 's clinical associations. RESULTS: expression had lower OS. CONCLUSION: could serve as a diagnostic and prognostic biomarker for NKTCL patients.